FCODF yields 0.38% · PFE yields 6.20%● Live data
📍 FCODF pulled ahead of the other in Year 1
Combined, FCODF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FCODF + PFE for your $10,000?
Compagnie de l'Odet operates in the transport and logistics, and communication sectors in France, Africa, the Americas, the Asia-Pacific, and other European countries. The company operates through Transportation and Logistics, Oil Logistics, Communication, and Electricity Storage and Systems segments. The Transportation and Logistics segment provides maritime, and air transport and logistics services. The Oil Logistics segment distributes oil products. The Communication segment engages in the sale of recorded music on physical media or digital form; exploitation of copyrights and services to artists; editing and distribution of pay and free television channels; production, sale, and distribution of motion pictures and TV series; design and publishing of downloadable video games for mobiles and consoles; and provision of ticketing services, and communication and advertising agency consultancy. The Electricity Storage and Systems segment produces and sells electric batteries for electric vehicles, terminals and specialized systems, and plastic films, as well as telecommunications activities. It also manages a portfolio of financial investments. The company was formerly known as Financière de l'Odet SA and changed its name to Compagnie de l'Odet in May 2021. The company was incorporated in 1929 and is headquartered in Paris, France. Compagnie de l'Odet is a subsidiary of Bolloré SE.
Full FCODF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.